Charles River Laboratories International, Inc. (CRL)
295.90
-2.68
(-0.90%)
USD |
NYSE |
Aug 25, 09:36
Charles River Laboratories International Shareholders Equity (Quarterly) : 2.840B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.840B |
| March 31, 2026 | 2.941B |
| December 31, 2025 | 3.165B |
| September 30, 2025 | 3.405B |
| June 30, 2025 | 3.353B |
| March 31, 2025 | 3.194B |
| December 31, 2024 | 3.462B |
| September 30, 2024 | 3.782B |
| June 30, 2024 | 3.723B |
| March 31, 2024 | 3.640B |
| December 31, 2023 | 3.597B |
| September 30, 2023 | 3.306B |
| June 30, 2023 | 3.252B |
| March 31, 2023 | 3.109B |
| December 31, 2022 | 2.976B |
| September 30, 2022 | 2.627B |
| June 30, 2022 | 2.648B |
| March 31, 2022 | 2.610B |
| December 31, 2021 | 2.535B |
| September 30, 2021 | 2.427B |
| June 30, 2021 | 2.318B |
| March 31, 2021 | 2.184B |
| December 31, 2020 | 2.115B |
| September 30, 2020 | 1.897B |
| June 30, 2020 | 1.753B |
| Date | Value |
|---|---|
| March 31, 2020 | 1.652B |
| December 31, 2019 | 1.635B |
| September 30, 2019 | 1.532B |
| June 30, 2019 | 1.455B |
| March 31, 2019 | 1.398B |
| December 31, 2018 | 1.317B |
| September 30, 2018 | 1.253B |
| June 30, 2018 | 1.182B |
| March 31, 2018 | 1.140B |
| December 31, 2017 | 1.045B |
| September 30, 2017 | 1.022B |
| June 30, 2017 | 963.50M |
| March 31, 2017 | 876.43M |
| December 31, 2016 | 836.77M |
| September 30, 2016 | 867.97M |
| June 30, 2016 | 831.35M |
| March 31, 2016 | 779.82M |
| December 31, 2015 | 733.07M |
| September 30, 2015 | 704.36M |
| June 30, 2015 | 701.70M |
| March 31, 2015 | 663.71M |
| December 31, 2014 | 672.20M |
| September 30, 2014 | 670.30M |
| June 30, 2014 | 671.82M |
| March 31, 2014 | 695.46M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| IQVIA Holdings, Inc. | 6.171B |
| Medpace Holdings, Inc. | 433.86M |
| Fortrea Holdings, Inc. | 524.20M |
| Avantor, Inc. | 5.630B |
| Champions Oncology, Inc. | 3.939M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.532B |
| Total Liabilities (Quarterly) | 4.644B |
| Debt to Equity Ratio | 1.069 |
| Current Ratio | 1.348 |
| Net Debt Paydown Yield | -0.08% |